SENP1 and ischemic cardiomyopathy: Translating our findings, our data suggests that using AAV9‐mediated Senp1 overexpression could alleviate the progression of a murine model of ischemic cardiomyopathy (ICM), offering promise for treating patients suffering from ischemic heart disease.